MYC and ovarian cancer: Because MYC is frequently amplified in high-grade serous ovarian cancer (HGSOC),2,43 we screen a panel of ovarian cancer cell lines and 30 patient-derived ovarian cancer models to identify molecular features that correlate with SAE inhibitor sensitivity.